Searched for
DAINIPPON SUMITOMO PHARMA
Nikkei ends at over 30-year high on hopes for expanded US stimulusThe benchmark Nikkei share average rose 1.63 per cent to 27,292.37, its highest closing level since Aug. 16, 1990, while also posting its b...- Nikkei closes flat even as chip makers make a buzzChip equipment makers jumped, tracking a rise in US tech shares overnight.
- Nikkei rebounds as Fed's shift calms nerves; gains 3.8% in JanuaryFor the month, the Nikkei gained 3.8 per cent, after diving 10.5 per cent last month.
- Nikkei falls, Dainippon Pharma's slide offsets Apple optimismThe Nikkei share average declined 0.5 per cent to 20,556.54, after opening a tad higher.
- Japanese companies make cautious return to Indian pharma marketOther drug companies whose acquisition went southwards included Mitsui & Co, which acquired a significant stake in Arch Pharma.
- Dr Reddy's Laboratories will infringe on Lunesta's patent: US court of appealThe United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the paten...
- Sensex reverses gains: Top eleven stocks in focusThe BSE Sensex quickly reversed gains in mid-morning trade and slipped in red. Take a look at top eleven stocks in focus.
- Dr Reddy's under pressure on losing appeal for LunestaDr Reddy's Laboratories were witnessing profit booking on reports that the company has lost a patent case for generic version of Lunesta.
- Eleven stocks in focus in Friday morning tradeIndian markets are likely to trade in a range. Here is a list of eleven stocks which are likely to be in focus in trade today.
- Lupin settles litigation over Lunesta with Japanese firmDrug firm Lupin on Monday said it has settled ongoing litigation over Lunesta tablets, used in treating insomnia, with Japan-based Dainippo...
Load More
